MSME (Udyam registered) Ministry of MSME
- Udyam number
- UDYAM-MH-18-0000431
Satyan Pharmaceuticals Private Limited - business outsourcing in Mumbai, Maharashtra, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹75.93 Cr
▼ 21% YoY
Net loss · FY 2025
₹14.08 Lakh
Net margin -0.2%
EBITDA · FY 2025
₹2.89 Cr
EBITDA margin 3.8%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Open charges
₹13.5 Lakh
Satisfied ₹2.04 Cr
Company age
40 yrs
Est. 1986
Directors on board
4
As per MCA filings
About Satyan Pharmaceuticals Private Limited
Data last updated:
Satyan Pharmaceuticals Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the business and IT consulting segment of the business process outsourcing sector. It was incorporated on 21 October 1986 and has been in existence for over 40 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24230MH1986PTC041306. Its GSTIN is 27AAGCS9818R1ZB (Maharashtra).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Yash Venilal Sanghavi (Managing Director) and Satyen Yeshwant Sanghavi.
Its last annual general meeting (AGM) was held on 30 October 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Mumbai, Maharashtra.
As per the financials filed for FY 2025, the company reported a revenue of ₹75.93 Cr, a decline of 21% compared to the previous year. For the same year it recorded a net loss of ₹14.08 Lakh (net margin -0.2%) and EBITDA of ₹2.89 Cr (EBITDA margin 3.8%). Revenue has declined at a compounded annual rate (CAGR) of 30% over three years and 11% over five years.
The company is associated with 1 brand: Satyan Pharmaceuticals. As per MCA filings, the company has open charges of ₹13.5 Lakh and satisfied charges of ₹2.04 Cr on record.
Satyan Pharmaceuticals Private Limited is registered as an MSME under the Udyam registration framework (Reg. No. UDYAM-MH-18-0000431). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website satyan-pharma.com.
Company details
CIN U24230MH1986PTC041306
Registration Number 041306
Incorporation Date 21 October 1986
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 October 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification MSME
Udyam Registration UDYAM-MH-18-0000431
Key People
Yash Venilal Sanghavi Managing Director Satyen Yeshwant Sanghavi Director Vasant Pundlik Mhatre Director Recognitions & Rankings of Satyan Pharmaceuticals
Contact details
Satyan Pharmaceuticals Private Limited's registered office is in Mumbai, Maharashtra. Its website is satyan-pharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered Address2nd Floor Unit No. 22 Hi Life Mall, P M Road Santacruz West, Mumbai, Maharashtra, India – 400054
- IndustryBusiness Outsourcing, Business & IT Consulting
To see the full contact details of Satyan Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Satyan Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Satyan Pharmaceuticals operates one associated brand: Satyan Pharmaceuticals. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Satyan Pharmaceuticals operates as a contract manufacturing organization for pharmaceutical products. | satyanpharma.com |
Business activity
The main business activity of Satyan Pharmaceuticals is professional, scientific and technical. In detail, this covers management consultancy activities.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| M | Professional, Scientific and Technical | M3 | Management consultancy activities |
To see the full business activity and turnover split of Satyan Pharmaceuticals Private Limited, buy the company report.
Financials of Satyan Pharmaceuticals Private Limited
FY 2025 filings availableSatyan Pharmaceuticals Private Limited reported revenue of ₹75.93 Cr (down 21% YoY) for FY 2025.
Revenue · FY 2025
₹75.93 Cr ▼ 21%
Net loss · FY 2025
₹14.08 Lakh margin -0.2%
EBITDA · FY 2025
₹2.89 Cr margin 3.8%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 21%
3 years · compounded
▼ 30%
5 years · compounded
▼ 11%
EBITDA CAGR growth
1 year
▼ 12%
3 years · compounded
▼ 46%
5 years · compounded
▼ 21%
Revenue has declined at a compounded annual rate (CAGR) of 11% over five years, including a 21% fall in the latest year. EBITDA fell 12% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹2.89 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹14.08 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 3.8% | ||||
| Net Profit Margin | -0.2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Satyan Pharmaceuticals Private Limited, buy the company report.
Board of directors of Satyan Pharmaceuticals Private Limited
Satyan Pharmaceuticals has 4 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Satyen Yeshwant Sanghavi | Director | 02 May 2008 | 18 Years 5 Months | Current |
| Vasant Pundlik Mhatre | Director | 25 Mar 2009 | 17 Years 7 Months | Current |
| Yash Venilal Sanghavi | Managing Director | 21 Oct 1986 | 40 Years 0 Months | Current |
| Bhavna Yash Sanghavi Also directs: Regrow Biosciences Private Limited | Director | 21 Oct 1986 | 40 Years 0 Months | Current |
Auditor
Satyan Pharmaceuticals Private Limited is audited by N A R A D AND ASSOCIATES LLP for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| N A R A D AND ASSOCIATES LLP | FY 2023 | 114500W |
Shareholding
The shareholding of Satyan Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Satyan Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
Open charges
₹13.5 Lakh
Satisfied charges
₹2.04 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 31 May 2025 | 101115194 | Hdfc Bank Limited | ₹13.5 Lakh | Open | |
| 09 Aug 2007 | 10106626 | 3I Infotech Trusteeship Services Limited | ₹1.9 Cr | Satisfied | |
| 12 Oct 2000 | 90225107 | New Indi Aco-Op Bank Ltd | ₹8.74 Lakh | Satisfied | |
| 04 Jun 1998 | 90224921 | New Indi Aco-Op Bank Ltd | ₹4.79 Lakh | Satisfied |
To see the full charge records of Satyan Pharmaceuticals Private Limited, buy the company report.
Total charge records: 4 View all charges
Legal cases
No court or tribunal cases involving Satyan Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Satyan Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Satyan Pharmaceuticals has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAGCS9818R1ZB | Maharashtra | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Satyan Pharmaceuticals Private Limited, buy the company report.
Recent activity
Satyan Pharmaceuticals Private Limited has 6 board changes on record since 1986: 5 appointments and 1 cessation. The latest: Manjeeri Rushit Desai ceased to be Director on 29 Sep 2012.
AGM
Satyan Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Oct 2025 as per latest MCA records.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 13.50 Lakh with Charge ID 101115194 was registered on 31 May 2025.
Filing
Satyan Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai I.
Ceased
Manjeeri Rushit Desai ceased to be Director.
Charges
A charge registered on 12 Oct 2000 via Charge ID 90225107 with New Indi Aco-Op Bank Ltd was fully satisfied on 26 Jul 2011.
Charges
A charge registered on 04 Jun 1998 via Charge ID 90224921 with New Indi Aco-Op Bank Ltd was fully satisfied on 26 Jul 2011.
Charges
A charge registered on 09 Aug 2007 via Charge ID 10106626 with 3I Infotech Trusteeship Services Limited was fully satisfied on 15 Sep 2010.
Appointed
Vasant Pundlik Mhatre was appointed as Director.
Appointed
Manjeeri Rushit Desai was appointed as Director.
Appointed
Satyen Yeshwant Sanghavi was appointed as Director.
Charges
A charge with 3I Infotech Trusteeship Services Limited amounted to Rs. 190.00 Lakh with Charge ID 10106626 was registered on 09 Aug 2007.
Charges
A charge with New Indi Aco-Op Bank Ltd amounted to Rs. 8.74 Lakh with Charge ID 90225107 was registered on 12 Oct 2000.
4 earlier events are in the company report.
Frequently asked questions
Satyan Pharmaceuticals is an active private limited company based in Mumbai, Maharashtra, India. The company works in business and IT consulting, within the business outsourcing industry. It was incorporated on 21 October 1986 (40+ years old) and is registered under CIN U24230MH1986PTC041306.
Satyan Pharmaceuticals has 4 current directors:
- Yash Venilal Sanghavi - Managing Director
- Satyen Yeshwant Sanghavi - Director
- Vasant Pundlik Mhatre - Director
- Bhavna Yash Sanghavi - Director
The latest financial statements of Satyan Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 October 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Satyan Pharmaceuticals is 27AAGCS9818R1ZB, registered in Maharashtra.
The CIN (Corporate Identification Number) of Satyan Pharmaceuticals is U24230MH1986PTC041306. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Satyan Pharmaceuticals was incorporated on 21 October 1986, making it 40+ years old. It is registered with the Registrar of Companies, Mumbai.
Manjeeri Rushit Desai ceased to be Director on 29 Sep 2012. Vasant Pundlik Mhatre was appointed as Director on 25 Mar 2009. Manjeeri Rushit Desai was appointed as Director on 02 May 2008. Satyan Pharmaceuticals has 6 board changes on record in total.
Yes, Satyan Pharmaceuticals is registered as an MSME under Udyam registration (number: UDYAM-MH-18-0000431).
Satyan Pharmaceuticals can be reached through the website satyan-pharma.com. Its registered office is in Mumbai, Maharashtra, India.
The registered office of Satyan Pharmaceuticals is at 2nd Floor Unit No. 22 Hi Life Mall, P M Road Santacruz West, Mumbai, Maharashtra, India – 400054.